- Gunawardana, Manjula;
- Webster, Simon;
- Rivera, Sofia;
- Cortez, John M;
- Breslin, Jessica;
- Pinales, Cristian;
- Buser, Christopher;
- Ibarrondo, F Javier;
- Yang, Otto O;
- Bobardt, Michael;
- Gallay, Philippe A;
- Adler, Amy P;
- Ramirez, Christina M;
- Anton, Peter A;
- Baum, Marc M
Background
A comprehensive understanding of the SARS-CoV-2 infection dynamics and the ensuing host immune responses is needed to explain the pathogenesis as it relates to viral transmission. Knowledge gaps exist surrounding SARS-CoV-2 in vivo kinetics, particularly in the earliest stages after exposure.Methods
An ongoing, workplace clinical surveillance study was used to intensely sample a small cohort longitudinally. Nine study participants who developed COVID-19 between November, 2020 and March, 2021 were monitored at high temporal resolution for three months in terms of viral loads as well as associated inflammatory biomarker and antibody responses. CD8 + T cells targeting SARS-CoV-2 in blood samples from study participants were evaluated.Results
Here we show that the resulting datasets, supported by Bayesian modeling, allowed the underlying kinetic processes to be described, yielding a number of unexpected findings. Early viral replication is rapid (median doubling time, 3.1 h), providing a narrow window between exposure and viral shedding, while the clearance phase is slow and heterogeneous. Host immune responses different widely across participants.Conclusions
Results from our small study give a rare insight into the life-cycle of COVID-19 infection and hold a number of important biological, clinical, and public health implications.